These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5580693)

  • 1. A comparative assessment of choline theophyllinate and sustained-release theophylline in patients attending a chest clinic.
    McIntosh D
    Br J Clin Pract; 1971 May; 25(5):233-5. PubMed ID: 5580693
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trial of Theograd.
    Brantingham P
    Br J Clin Pract; 1970 Apr; 24(4):165-7. PubMed ID: 4909447
    [No Abstract]   [Full Text] [Related]  

  • 3. Slow release theophylline in chronic bronchitis--a comparative study.
    Evans WV
    Br J Clin Pract; 1986 Jun; 40(6):245-50. PubMed ID: 3741733
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].
    Kaik G
    Wien Med Wochenschr; 1984 Apr; 134(7):163-9. PubMed ID: 6741156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained-release theophylline in chronic bronchitis.
    Anderson G; Peel ET; Pardoe T; Jones R
    Br J Dis Chest; 1982 Jul; 76(3):261-5. PubMed ID: 6751366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow release theophyllines and chronic bronchitis.
    Cochrane GM
    Br Med J (Clin Res Ed); 1984 Dec; 289(6459):1643-4. PubMed ID: 6439357
    [No Abstract]   [Full Text] [Related]  

  • 7. A single-blind crossover study of two different slow release theophylline preparations.
    Tatsis G; Danos J; Gaga M; Pantelakis D; Veslemes M; Jordanoglou J
    J Int Med Res; 1988; 16(6):452-8. PubMed ID: 3069520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of protheo on pulmonary function and the change of its plasma concentration in patients with chronic asthmatic bronchitis].
    Li S; Chen Y; Tan P
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Oct; 20(5):299-300. PubMed ID: 10374457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained-release theophylline preparations.
    Drug Ther Bull; 1985 May; 23(9):33-6. PubMed ID: 3888583
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative bioavailability of 2 oral theophylline sustained-release preparations].
    Tritthart W; Lücker PW; Fáy E; Buchebner J
    Arzneimittelforschung; 1983; 33(11):1603-6. PubMed ID: 6686457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled study of slow-release theophylline and aminophylline in patients with chronic bronchitis.
    Jenkins PF; White JP; Jariwalla AJ; Anderson G; Campbell IA
    Br J Dis Chest; 1982 Jan; 76(1):57-60. PubMed ID: 7037034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of 2 theophylline delayed-action preparations of different galenic forms].
    Hirsch H
    Wien Med Wochenschr; 1983 Aug; 133(15-16):403-8. PubMed ID: 6636797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical trial of ventax (long-acting theophylline) in chronic obstructive bronchitis].
    Nikitina AV; Karpukhina EP; Lapygina MV; Evstratov AI
    Klin Med (Mosk); 1997; 75(1):40-1. PubMed ID: 9082058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability of sustained-release theophylline formulations.
    Bonora Regazzi M; Rondanelli R; Vidale E; Cristiani D
    Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):245-51. PubMed ID: 6862729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum theophylline steady-state levels: comparative study of 2 retard preparations].
    Kaukel E; Koppermann G
    Prax Klin Pneumol; 1983 Mar; 37(3):109-12. PubMed ID: 6856560
    [No Abstract]   [Full Text] [Related]  

  • 16. Roxithromycin and controlled release theophylline, an interaction study.
    Bandera M; Fioretti M; Rimoldi R; Lazzarini A; Anelli M
    Chemioterapia; 1988 Oct; 7(5):313-6. PubMed ID: 3224399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of slow-release theophylline on airway inflammation in bronchial asthma].
    Adachi M; Minoguchi K; Mita S; Kokubu F; Suzuki H; Sano Y; Akiyama K; Yasuhara H
    Arerugi; 1998 Aug; 47(8):734-43. PubMed ID: 9796114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled-release theophylline and proxyphylline in asthmatics: a comparative study.
    Mosbech H; Paulsen H; Søborg M
    Pharmatherapeutica; 1984; 3(9):626-30. PubMed ID: 6374684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R
    Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tolerability of a new oral controlled release theophylline preparation in patients with obstructive airways diseases.
    Nolte D; Dusik B
    Br J Clin Pract Suppl; 1984; 32():18-21. PubMed ID: 6432018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.